BiotechTube

Voclosporin + Placebo Oral Capsule

Phase 3Terminated
0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Adolescent Lupus Nephritis

Conditions

Adolescent Lupus Nephritis, Pediatric Lupus Nephritis

Trial Timeline

Oct 10, 2023 → Jul 3, 2025

NCT ID
NCT05288855

About Voclosporin + Placebo Oral Capsule

Voclosporin + Placebo Oral Capsule is a phase 3 stage product being developed by Aurinia Pharmaceuticals for Adolescent Lupus Nephritis. The current trial status is terminated. This product is registered under clinical trial identifier NCT05288855. Target conditions include Adolescent Lupus Nephritis, Pediatric Lupus Nephritis.

What happened to similar drugs?

0 of 4 similar drugs in Adolescent Lupus Nephritis were approved

Approved (0) Terminated (1) Active (3)
🔄Exenatide Once Weekly + PlaceboAstraZenecaPhase 3
🔄Placebo + IBI362Innovent BiologicsPhase 3
❌voclosporinAurinia PharmaceuticalsPhase 3
🔄rizatriptan benzoateOrganonPhase 3

Hype Score Breakdown

Clinical
17
Activity
0
Company
9
Novelty
0
Community
0

Clinical Trials (3)

NCT IDPhaseStatus
NCT05288855Phase 3Terminated
NCT03597464Phase 3Completed
NCT03021499Phase 3Completed

Competing Products

8 competing products in Adolescent Lupus Nephritis

See all competitors
ProductCompanyStageHype Score
LorcaserinEisaiPhase 1
29
RSS0343 TabellaJiangsu Hengrui MedicinePhase 2
42
Exenatide Once Weekly + PlaceboAstraZenecaPhase 3
40
Placebo + IBI362Innovent BiologicsPhase 3
47
IBI362 + IBI362 placeboInnovent BiologicsPhase 1
29
Antipsychotics, mood stabilizers, etc.Brain BiotechPre-clinical
23
voclosporinAurinia PharmaceuticalsPhase 3
26
rizatriptan benzoateOrganonPhase 3
34